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ABSTRACT Nonalcoholic fatty liver disease (NAFLD), largely studied as a condition
of overnutrition, also presents in undernourished populations. Like NAFLD, undernu-
trition disrupts systemic metabolism and has been linked to gut microbiota dysbio-
sis. Indeed, chronic exposures to fecal microbes contribute to undernutrition pathol-
ogy in regions with poor sanitation. Despite a growing prevalence of fatty liver
disease, the influence of undernutrition and the gut microbiota remain largely unex-
plored. Here, we utilize an established murine model (C57BL/6J mice placed on a
malnourished diet that received iterative Escherichia coli/Bacteroidales gavage [MBG
mice]) that combines a protein/fat-deficient diet and iterative exposure to specific,
fecal microbes. Fecal-oral contamination exacerbates triglyceride accumulation in un-
dernourished mice. MBG livers exhibit diffuse lipidosis accompanied by striking shifts
in fatty acid, glycerophospholipid, and retinol metabolism. Multiomic analyses re-
vealed metabolomic pathways linked to the undernourished gut microbiome and
hepatic steatosis, including phenylacetate metabolism. Intriguingly, fatty liver fea-
tures were observed only in the early-life, but not adult, MBG model despite similar
liver metabolomic profiles. Importantly, we demonstrate that dietary intervention
largely mitigates aberrant metabolomic and microbiome features in MBG mice.
These findings indicate a crucial window in early-life development that, when dis-
rupted by nutritional deficiency, may significantly influence liver function. Our work
provides a multifaceted study of how diet and gut microbes inform fatty liver pro-
gression and reversal during undernutrition.
IMPORTANCE Nonalcoholic fatty liver disease (NAFLD) remains a global epidemic,
but it is often studied in the context of obesity and aging. Nutritional deficits, how-
ever, also trigger hepatic steatosis, influencing health trajectories in undernourished
pediatric populations. Here, we report that exposure to specific gut microbes im-
pacts fatty liver pathology in mice fed a protein/fat-deficient diet. We utilize a multi-
omics approach to (i) characterize NAFLD in the context of early undernutrition and
(ii) examine the impact of diet and gut microbes in the pathology and reversal of
hepatic steatosis. We provide compelling evidence that an early-life, critical develop-
ment window facilitates undernutrition-induced fatty liver pathology. Moreover, we
demonstrate that sustained dietary intervention largely reverses fatty liver features
and microbiome shifts observed during early-life malnutrition.
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Obesity-associated nonalcoholic fatty liver disease (NAFLD), with a global preva-lence over 25%, remains a leading cause of liver disease around the world (1).
While NAFLD incidence increases with age, recent studies estimate that NAFLD also
affects 3 to 12% of the pediatric population (1, 2).
Up to 30% of NAFLD cases may progress to NASH (nonalcoholic steatohepatitis), a
reversible condition characterized by hepatocellular ballooning, inflammation, and
fibrosis (3, 4). As NASH advances, irreversible damage, including liver cirrhosis or
hepatocellular carcinogenesis, may occur (5, 6). Linked to obesity and diabetes mellitus,
NAFLD is considered both a driver and manifestation of metabolic syndrome, and it has
been largely examined as a consequence of overnutrition (1, 7). Severe undernutrition,
however, has also been shown to promote fatty liver through impaired lipid metabo-
lism (8–10).
Over 10% of the worldwide population experiences undernutrition (11). Malnutri-
tion accounts for nearly half of all deaths in children under the age of five (12). A critical,
environmental burden contributing to the persistence of early-life malnutrition is
fecal-oral contamination. Poor sanitation, including the lack of clean drinking water and
access to hygienic toilet facilities, promotes chronic exposure to fecal microbes. These
microbial exposures alter the gut microbiota and impair nutrient absorption (12–15). In
pediatric populations, fecal-oral contamination and subsequent gut dysbiosis are linked
to growth stunting and lasting malnutrition consequences, from neurocognitive im-
pairment to poor metabolic function (14, 16–18).
Both undernutrition and gut microbes shape health trajectories, including systemic
metabolic activity (12, 13, 16). Indeed, the gut microbiome has been implicated in fatty
liver as changes in microbial composition and function, notably alterations of
bacterium-mediated bile acid metabolism, have been reported in obese-associated
NAFLD (5, 19). However, the precise influence of fecal-oral contamination on the
etiology, pathology, and persistence of undernutrition-triggered fatty liver remains
largely unexplored.
We previously reported chronic fecal exposures, via bacterial gavage, trigger growth
faltering, gut dysbiosis, and broad metabolic alterations in malnourished mice—
C57BL/6J mice placed on a malnourished diet that received iterative E. coli/Bacteroi-
dales gavage (MBG) model (13, 20). The MBG bacterial gavage is comprised of specific
fecal commensals (Escherichia coli/Bacteroidales). Subsequent MBG bacterial coloniza-
tion not only reflects increased relative abundance of E. coli and Bacteroidales com-
mensals reported in pediatric malnourished communities but also elicits gastrointesti-
nal and immune features linked to fecal-oral contamination (13, 20–22). In an
independent research study, colonization by E. coli and Bacteroidetes members, origi-
nally isolated from a malnourished pediatric microbiota, impaired weight gain in a
murine model of malnutrition (21).
We have previously reported that E. coli/Bacteroidales exposures fail to robustly
colonize the gut or trigger growth deficits in control (CON) mice. Furthermore, we
demonstrated that enteric Salmonella enterica serotype Typhimurium infection in-
creased hepatic lipidosis and inflammatory markers within the MBG liver, accompanied
by a striking increase of hepatic S. Typhimurium burden. Enteric infection, however,
failed to trigger immune and hepatic alterations in CON mice repeatedly exposed to E.
coli/Bacteroidales (13). These reported findings indicate that the deleterious effects of E.
coli/Bacteroidales fecal exposures require malnutrition. Whether fecal-oral contamina-
tion promotes fatty liver features in the absence of enteric insult remained undeter-
mined.
Here, we show that exposure to specific fecal commensals (Escherichia coli/Bacte-
roidales) exacerbates triglyceride accumulation in the context of undernutrition. MBG
livers display diffuse macrovesicular lipidosis accompanied by a striking shift in the liver
metabolome, notably polyunsaturated fatty acid (PUFA) and retinol metabolism. Mul-
tiomic analyses linked phenylacetate and glycerophospholipid metabolism to hepatic
steatosis and the MBG gut microbiome. Fatty liver histology was observed only in
young mice, not in adult mice, exposed to MBG conditions. Importantly, we demon-
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strate that dietary intervention reversed fatty liver pathology and largely mitigated gut
microbiota compositional and functional alterations, putatively driving undernutrition-
induced fatty liver. Our work indicates a critical window of metabolic development that,
when disrupted, may significantly impact liver function. Moreover, this study reveals
the complexity of fatty liver pathology, characterizing a multihit model involving
diverse metabolomic and microbial alterations. We anticipate that these findings will
provide valued insights into the roles of diet and gut microbes in driving fatty liver
pathology, highlighting potential therapeutic targets to address undernutrition-
induced fatty liver.
RESULTS
Malnutrition and fecal-oral contamination promote fatty liver features. To
explore the influence of diet and fecal gut commensals on liver function, we utilized the
MBG murine model, an established malnutrition model previously characterized by our
lab (13, 20). Briefly, newly-weaned C57BL/6J mice were placed on a malnourished diet
(MAL mice). This protein/fat-deficient, carbohydrate-rich diet reflects dietary shifts
previously reported in undernourished communities (13, 23–25). To model chronic fecal
exposure, a subset of MAL mice received iterative E. coli/Bacteroidales gavage (MBG
mice). Control (CON) mice, placed on a standard chow diet of equivalent caloric value,
provided a healthy control (Fig. 1A).
We further characterized malnourished growth deficits with X-ray micro-computed
tomography (micro-CT) (five mice per group). Following micro-CT scanning, three-
dimensional images were reconstructed, and bone, lean, and adipose tissues were
segmented using MicroView software (Fig. 1B). MAL and MBG mice exhibited a modest,
albeit not significant, decrease in total volume (see Fig. S1A in the supplemental
material). Fecal-oral contamination exacerbated growth alterations, notably loss of
bone and lean body percentage. In contrast, both total volume and percentage of
adipose tissues increased within MAL and MBG mice (Fig. 1B and C and Fig. S1),
indicative of impaired nutrient storage and metabolism, a process requiring healthy
liver function (26).
After 4 weeks on the malnourished diet, MAL and MBG livers exhibit a paler
appearance, suggestive of fatty liver (Fig. 2A). Despite visual discrepancies, liver weights
and body-normalized liver weights were comparable across conditions (Fig. S2A).
Hematoxylin and eosin (H&E) staining revealed diffuse hepatic steatosis throughout
malnourished livers (Fig. 2A). While MAL and MBG mice exhibit comparable fat-
associated space within the liver histology (fasted mice), fecal-oral contamination
exacerbated hepatic fat/glycogen steatosis (nonfasted mice) and triglyceride levels
during malnutrition (Fig. 2B and C and Fig. S2B). Despite fatty liver features, both MAL
and MBG mice lacked histological evidence of significant steatohepatitis associated
with NASH and inflammatory profiling revealed similar cytokine levels (gamma inter-
feron [IFN-], interleukin 6 [IL-6], IL-12, monocyte chemotactic peptide 1 [MCP-1], and
tumor necrosis factor alpha [TNF-]) across CON, MAL, and MBG livers (Fig. S2C).
As overnutrition-associated NAFLD and metabolic syndrome are highly connected
(7), we also assessed clinical features of metabolic disruption. Insulin levels were
comparable across groups under nonfasting and fasting conditions. While nonfasting
mice exhibited comparable glucose concentrations, fasting glucose levels were ele-
vated within MAL and MBG sera, possibly indicative of early insulin resistance and
altered glucose metabolism (Fig. S2D). These results indicate that MAL/MBG mice
display undernutrition-induced fatty liver features, with fecal-oral contamination pro-
moting fat/glycogen-associated steatosis and impaired triglyceride metabolism.
To further characterize metabolic shifts, we conducted untargeted metabolomics for
less polar and polar metabolites via reversed-phase ultrahigh-performance liquid chro-
matography–Fourier transform mass spectrometry (RP-UPLC-FTMS) and hydrophilic
interaction chromatography-FTMS (HILIC-FTMS), respectively, with four mice per group.
Over 1,000 differentially abundant hits were detected following FTMS (one-way analysis
of variance [ANOVA] Fisher’s least significant difference [LSD], adjusted P value [cor-
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rected for the false discovery rate] [Padj]  0.05). Of these hits, 350 differentially
abundant metabolic features were annotated using the METLIN database. Diet pre-
dominantly shifted the liver metabolome as reported by unsupervised principal-
component analysis (PCA) (Fig. 3A), and pathway analyses found no significantly
enriched MAL versus MBG metabolomic pathways following false-discovery rate (FDR)
correction (data not shown). Subsequent metabolite set enrichment analyses using
Metaboanalyst 4.0 focused on dietary-driven metabolomic shifts (27).
Metabolite set enrichment analysis identified phosphatidylethanolamine (PE) bio-
synthesis, sphingolipid metabolism, and phospholipid biosynthesis as the top enriched
metabolomic pathways identified in malnourished (MAL and MBG) livers (Fig. 3B),
metabolic shifts observed in both undernutrition and hepatic steatosis models (13, 28).
FIG 1 Malnourished model displays altered growth. (A) CON, MAL, and MBG experimental groups of 3-week-old mice were placed on control or malnourished
diets. A subset of mice on the malnourished diet receive iterative bacterial gavage after 2 weeks (MBG mice). Liver features were examined 4 weeks following
experimental start. The colors of the lines indicating diet and treatment are utilized to indicate murine groups in subsequent figures. (B) Representative images
from reconstructed micro-CT scans. Mid-coronal plane with lean and adipose tissue highlighted in blue and green, respectively, is overlaid on surface-rendered
bone tissue (white) (five mice per group). (C) Percent lean, bone, and adipose tissues from murine body (shoulder blade to tail). Bars indicate means  standard
errors of the means (SEM) (error bars). Statistical significance was determined by Kruskal-Wallis with post hoc Dunn’s test and indicated as follows: *, P  0.05;
**, P  0.01; ns, not significant.
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Compared to malnourished counterparts, CON livers exhibit enriched pathways linked
to bile and PUFA metabolism, specifically -linolenic acid (LA) and linoleic acid (LA)
metabolism (Fig. 3B), broadly reflecting shifts previously reported within the healthy
small intestine (13).
To extend untargeted metabolomic data, we conducted fatty acid profiling of total
fatty lipids from liver tissue via gas chromatography. Malnourished mice displayed a
reduction in saturated fatty acid (SFA) percent content (Fig. 4A). In contrast, malnutri-
tion elevated relative unsaturated fatty acid (UFA) percent content (Fig. S3A). This
increase was largely driven by monounsaturated fatty acid (MUFA) content, as MAL and
MBG livers display nearly half the PUFA mol% of CON livers (Fig. 4A and B).
Dietary LA and LA serve as precursors to downstream 6 and 3 PUFAs, respec-
tively. MAL and MBG mice exhibit a persistent loss of LA and LA metabolism
supporting metabolic enrichment analyses (Fig. 3B and Fig. 4A and B). Elevated 6/3
ratios—an inflammatory marker often associated with Western diets, have been asso-
ciated with NALFD and NASH (29, 30). In our model, healthy and malnourished mice
exhibit comparable 6/3 ratios (Fig. S3B), further suggesting that moderate malnu-
trition may trigger hepatic steatosis uncoupled from significant inflammation.
Dietary intervention largely reverses fecal microbiota shifts and fatty liver
features. We next sought to assess whether malnutrition and fecal-oral contamination
intensifies fatty liver features specifically within early critical windows (childhood) or
FIG 2 Malnutrition and fecal-oral contamination promote fatty liver features. (A) Representative whole liver (left) and
H&E-stained liver histology (right). Malnourished livers exhibit microvesicular steatosis (hepatocyte lipid accumulation) and
macrovesicular steatosis (hepatocyte lipid accumulation characterized by a large fat vacuole and displaced cell nucleus).
Representative examples of microvesicular steatosis and macrovesicular steatosis are adjacent to the black chevron or
double chevron, respectively. (B) Percent of fat-associated space (open spaces) in liver histology images, assessed with
ImageJ software. Each point represents a biological sample. (C) Triglyceride level normalized to liver weight. Data were
pooled from three experiments with triglyceride levels normalized to the CON group of each experiment. Bars indicate
means  SEM. Statistical significance was determined by Kruskal-Wallis with post hoc Dunn’s test (histology) or one-way
ANOVA with post hoc Dunnett’s test (triglycerides) and indicated as follows: **, P  0.01; ****, P  0.0001.
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whether these perturbations trigger comparable fatty liver features in adult mice.
Furthermore, we explored whether dietary intervention halts or reverses fatty liver
pathology of early-life malnutrition.
To address these unknowns, we conducted diet reversal experiments with eight
mice per group. As MAL and MBG mice exhibited similar liver metabolomic profiles, we
chose to utilize the MBG model during subsequent intervention studies. CON and MBG
mice served as healthy and undernutrition-induced fatty liver controls, respectively.
Following the initial 4-week phase, a subset of control mice was switched to the MBG
model—C-MBG (adult-onset malnutrition)—while a subset of MBG mice received the
control diet—MBG-R (reversal arm)—in order to assess the impact of dietary interven-
tion on MBG fatty liver, model set-up reported in Fig. 5A.
After early-life malnutrition (7-week time point), MBG mice displayed significant
weight faltering (t  3.73, P  0.0008). During the subsequent reversal phase, C-MBG
mice exhibited a modest, but not significant, weight loss. The final weights of MBG-R
mice, however, were comparable with those of CON and C-MBG mice by week 11
(F3,28  6.786, P  0.0014; Fig. 5B). We observed no significant difference in tail size at
week 11, suggesting that tail length differences previously reported in young malnour-
ished mice (13), are largely resolved by adulthood and not influenced by adult-onset
malnutrition (Fig. S4A).
As we introduce E. coli/Bacteroidales commensals in the initial malnutrition phase
(MBG and MBG-R) and reversal phase (C-MBG), we also assessed fecal microbiota
composition by 16S rRNA sequencing across time with fecal pellets taken upon
weaning (arrival), after the initial malnutrition phase (week 7), and following reversal
(week 11) and report the relative abundance of bacterial members by family classifi-
FIG 3 Malnutrition drives altered liver metabolome. (A) PCA plots of untargeted metabolomics via RP-UPLC-FTMS (top) and HILIC-FTMS (bottom). Data are from
the positive ion channel (four mice per group). (B) Metabolite set enrichment analyses conducted with Metaboanalyst v 4.0 reported alterations in metabolomic
pathways in the malnourished (MAL and MBG) and healthy (CON) liver. Metabolomic pathways to the right of the dashed red bar exhibit 1.5-fold enrichment
compared to background metabolomic database. Fold enrichment is determined as the number of observed pathway hits divided by the number of expected
hits. Untargeted metabolomics from the same experiment. The full metabolomic pathway names of the pathways with asterisks follow: *Alpha Linolenic Acid
and Linoleic Acid Metabolism, **Mitochondrial Beta-Oxidation of Long-Chain Fatty Acids.
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cation (Fig. S4B and Fig. 5C). The relative abundance of specific bacterial gavage
members was increased in C-MBG and/or MBG and/or MBG-R mice, but not CON
animals (Fig. S4C).
PCA of unweighted UniFrac distances revealed distinct clustering by dietary group
(CON and MBG) at week 7 (Fig. 5D). This MBG cohort exhibited increased -diversity
(Faith’s phylogenetic diversity [PD], Kruskal-Wallis: H  7.71, P  0.05; see Table S1 in
the supplemental material). Upon reversal parameters, the fecal microbiota composi-
tion of C-MBG and MBG-R composition significantly shifted toward MBG and CON,
respectively, as observed in unweighted UniFrac PCA and UniFrac distance metrics (Fig.
5D, Fig. S4D, and Table S1). Moreover, dietary intervention reduced MBG-R -diversity,
a pattern observed in CON counterparts, while C-MBG mice exhibited increased
-diversity (Faith’s PD, Kruskal-Wallis: H  9.04, P  0.03) (Table S1).
Diet significantly influenced the relative abundance of select bacterial members
with family and genus annotations reported in Fig. 5E and Fig. S4E. Bacteria from
Coriobacteriaceae (H  19.034, Padj  0.002) and Streptococcaceae families (H  22.537,
Padj  0.001) exhibit divergent shifts in response to malnourished diet. The relative
abundance of Coriobacteriaceae species increased upon malnutrition, while dietary
intervention somewhat mitigated Coriobacteriaceae bloom in MBG-R mice. Increased
relative abundance of Coriobacteriaceae has been reported in rodent models following
chronic stress (31, 32), suggesting that this bacterial family may be a marker of systemic
strain. In contrast, the relative abundance of Streptococcaceae bacteria was decreased
in malnourished mice (C-MBG and MBG), while MBG-R mice displayed increased relative
FIG 4 Malnutrition affects hepatic fatty acid liver profiles. (A) Fatty acid profiles in CON, MAL, and MBG livers determined by gas
chromatography: total SFA, MUFA, and PUFA mol%. (B) The relative abundances of 6 and 3 PUFAs normalized to CON values are shown.
In addition to LA and LA, major PUFAs include DGLA (dihomo--linolenic acid), AA (arachidonic acid), and DHA (docosahexaenoic acid).
Fatty acid profiling from the same experiment. Bars indicate means  SEM. Statistical significance was determined by ANOVA with post
hoc Dunnett’s test and indicated by asterisks as follows: *, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001.
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abundance approaching CON abundance. Like Streptococcaceae, Erysipelotrichaceae
bacteria have been linked with higher fat intake (33, 34). However, the relative
abundance of Erysipelotrichaceae remained elevated in C-MBG mice and reduced in
MBG-R mice (H  16.366, Padj  0.005), matching the original, early-life diet. This
finding may indicate that early-life malnutrition sets a long-term trajectory for Erysip-
elotrichaceae abundance, which is resilient against sustained dietary shifts during
murine adulthood. Relative abundance of Peptostreptococcaceae was also increased in
CON mice (H  15.366, Padj  0.005), but showed a striking reduction in the C-MBG,
MBG, and MBG-R gut microbiota, suggesting that bacteria within this family are highly
sensitive to malnourished diet and may not recover, even after prolonged dietary
intervention.
FIG 5 Dietary intervention improves growth deficits and alters gut microbiota composition. (A) Reversal experimental set-up: following 4 weeks on a healthy
or malnourished murine chow diet, a subset of healthy and malnourished mice were “reversed” on the opposite diet to assess impacts of adult-onset
malnutrition (C-MBG) and dietary intervention (MBG-R), respectively (eight mice per group). (B) Mouse weights across time. At 11 weeks, MBG-R mice exhibit
a significant weight improvement. (C) 16S rRNA microbiota analyses from murine individual stool samples. Relative abundance of bacteria by family
classification at the final time point is shown. (D) Unweighted UniFrac PCA with -diversity (Faith’s phylogenetic diversity) of the CON and MBG microbiota (left)
and the CON, C-MBG, MBG, and MBG-R microbiota (right). Each symbol represents the value for an individual mouse, and symbol shape reveals reversal diet.
(E) Select bacterial family members at week 11. The short horizontal lines indicate the medians. Samples were from the same murine experiment. Microbiome
analyses were conducted using QIIME2 (v. 2018.2). Statistical significance was determined by one-way ANOVA with post hoc Tukey’s test (growth) or
Kruskal-Wallis with post hoc Dunn’s test in panel E and indicated by asterisks as in the legend to Fig. 4.
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As these alterations may reflect model-specific bacterial shifts, we also predicted
microbiome metabolic signatures of health and malnutrition using predictive PICRUSt
analyses (35). Like compositional alterations, metabolic pathways of the C-MBG and
MBG-R microbiota largely shifted toward MBG and CON counterparts, respectively,
highlighting a robust microbial response to diet. Top differentially abundant PICRUSt
hits following FDR correction included amino acid biosynthesis and degradation path-
ways, broadly matching metabolomic patterns between CON and MAL intestinal
content (13). In addition, malnourished mice (MBG and C-MBG) exhibited elevated
pathways contributing to the tricarboxylic acid cycle (TCA) (or citric acid cycle), poten-
tially reflecting increased carbohydrate load in the MAL diet (Fig. S4F and Table S2).
Fecal-oral contamination and diet drive lasting features of early-life malnutrition,
notably physical stunting and gut dysbiosis. Our findings suggest that sustained dietary
intervention considerably mitigates these consequences in our early-life malnourished
model.
Dietary reversal also mitigated fatty liver features. CON hepatocytes exhibited
low-fat/glycogen content as observed by H&E staining, while 11-week-old MBG livers
displayed increased hepatic macrovesicular lipidosis compared to 7-week-old MBG
mice. Unexpectedly, undernutrition-induced fatty liver histology was not observed in
either C-MBG or MBG-R livers (Fig. 6A and B). In contrast, triglyceride content was
significantly elevated in both C-MBG and MBG mice, while triglyceride levels in MBG-R
livers were comparable with those in CON mice (Fig. 6C).
PCA of untargeted metabolomics for both less polar and polar metabolites con-
firmed a significant change in liver metabolomes, with the C-MBG and MBG-R metabo-
lomic profile shifting toward MBG and CON, respectively (Fig. 7A). Over 2,000 differen-
tially abundant hits were detected following RP-UPLC-FTMS and HILIC-FTMS analyses
FIG 6 C-MBG and MBG-R mice lack fatty liver features. (A) Representative H&E staining of the liver
following dietary reversal. (B) Percentage of fat/glycogen-associated space in nonfasted liver histology
determined with ImageJ analysis. Each symbol represents the value for a biological sample. (C) Total
triglyceride content in liver normalized to tissue weight. Data were normalized to CON levels. Analyses
conducted from murine tissue of the same experiment. Bars indicate means  SEM. Statistical signifi-
cance was determined by one-way ANOVA with post hoc Tukey’s test and indicated as in the legend to
Fig. 4.
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(one-way ANOVA Fisher’s LSD, Padj  0.05). Nearly 800 differentially abundant hits
were putatively annotated by m/z values against the METLIN database.
We first explored metabolomic distinctions between chronic, early-onset malnutri-
tion (MBG) and adult-onset malnutrition (C-MBG). While MBG and C-MBG livers exhibit
largely similar metabolomic profiles (Fig. 7A), we identified metabolites elevated in
persistent early malnutrition versus adult-onset malnutrition (45 metabolites: MBG
enriched over C-MBG plus MBG enriched over CON) for metabolite set enrichment
analyses. The top enriched pathway for the MBG profile was phenylacetate metabolism
(Fig. 7B), a bacterial product from aromatic amino acid metabolism (AAAM) linked to
hepatic steatosis (36). To explore whether the malnourished microbiome might con-
tribute to enriched phenylacetic acid metabolism, we returned to predictive micro-
biome PICRUSt analyses. The MBG microbiome exhibits significantly elevated AAAM
pathways compared to healthy controls (ARO-PWY, Padj  0.001; COMPLETE-ARO-PWY,
Padj  0.002). While these predicted pathways did not reach statistical significance
postreversal in CON, C-MBG, MBG, and MBG-R samples (ARO-PWY, Padj  0.105;
COMPLETE-ARO-PWY, Padj  0.078), the relative frequency of AAAM pathways was
higher in the MBG microbiome than in the C-MBG microbiome, as well as the micro-
biome of mice fed a healthy diet (CON and MBG-R), indicating a putative causal role for
the MBG microbiota in undernourished-induced fatty liver (Fig. S5).
We then categorized MBG-R metabolomic features as “reversible” or “resilient” to
dietary intervention. We considered reversible metabolites as those significantly differ-
ent between MBG-R and MBG but not MBG-R and CON, while resilient metabolites were
significantly altered between MBG-R and CON but not MBG-R and MBG. Of the
differentially abundant metabolite hits, 505 were categorized as reversible, while only
106 metabolite features were considered resilient, supporting robust reversal of the
fatty liver metabolome upon dietary intervention (Fig. 7C). Metabolites were then
classified and grouped into metabolomic pathways using the small molecule pathway
database (SMPDB). Adaptive immune pathways—B cell receptor (BCR) signaling path-
way and T cell receptor signaling pathway—were observed in both reversible and
resilient metabolomic profiles. The resilient profile featured many pathways associated
with arachidonic acid (AA) metabolism within the liver. In contrast, the reversible profile
included metabolites contributing to retinol (vitamin A1) metabolism. Moreover, nearly
FIG 7 Dietary reversal significantly shapes liver metabolome. (A) PCA plots of untargeted liver metabolomics via RP-UPLC–FTMS (top) and HILIC-FTMS (bottom).
Data from the positive ion channel are shown. (B) Metabolite set enrichment analyses conducted with Metaboanalyst v 4.0 (SMPDB database) reported enriched
metabolomic pathways in the MBG versus C-MBG liver metabolome. Metabolomic pathways to the right of the dashed red bar exhibit 1.5-fold enrichment.
Fold enrichment was determined as number of observed pathway hits divided by the number of expected hits. (C) Metabolomic pathway profiles of reversible
(top) and resilient (bottom) metabolites. One-way ANOVA of metabolites with post hoc Fisher’s LSD revealed metabolites significantly altered between MBG-R
and MBG but not MBG-R and CON (reversible) as well as metabolites altered between MBG-R and CON but not MBG-R and MBG (resilient). Metabolites were
searched in SMPDB to identify biopathway(s). The numbers of metabolites belonging to reversible or resilient pathway is shown in a gray circle; the adjacent
numeric value refers to the total number of pathways within each graph. Legend lists are from SMPDB pathways. (D) Retinol, retinal, and retinoic acid levels
within hepatic livers conducted by targeted LC-MS and normalized to tissue weights. Analyses were conducted from mice of the same reversal study. Bars
indicate means  SEM. Statistical significance was determined by one-way ANOVA with post hoc Tukey’s test and indicated as in the legend to Fig. 4.
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60% of reversible metabolites were involved in lipid and fatty acid metabolism, notably
amino acid metabolism and various phospholipid biosynthesis pathways (Fig. 7C).
To confirm untargeted metabolomic profiling, we assessed vitamin A metabolites
and profiled long-chain fatty acids following dietary reversal. While the healthy and
malnourished diets have distinct macronutrient profiles (e.g., reduced fat, elevated
carbohydrates), both diets contain identical micronutrient content, including vitamin
availability (13). Following absorption within the small intestine, dietary retinol can be
esterified into retinyl ester (storage form) or oxidized to retinal and retinoic acid (37).
We quantified retinoid levels within murine liver tissue with liquid chromatography
(LC)-MS. While retinol levels were comparable across groups, malnourished mice (MBG
and C-MBG) displayed reduced retinal and retinoic acid levels. As expected from
metabolomic pathway analyses, dietary intervention mitigated retinoid shifts in MBG-R
mice (Fig. 7D), supporting a reversible metabolic pattern.
As altered retinol metabolism also influences fatty acid metabolism (38), we as-
sessed long-chain fatty acid profiles following dietary reversal. Fatty acid profiles of
11-week-old CON and MBG livers exhibit patterns similar to those of their 7-week
counterparts (Fig. 4A and B and Fig. S3A). As expected, SFA and PUFA percent content
remained elevated within healthy livers and reduced in malnourished mice, while the
MBG liver displayed increased MUFA mol% (Fig. 8A). The reversal (end) diet, rather than
early-life diet, shaped fatty acid content as C-MBG and MBG livers exhibited fatty acid
profiles similar to those of MBG and CON livers, respectively (Fig. 8A and B and Fig. S6A).
We specifically assessed whether dietary intervention increased the relative abundance
FIG 8 Altered long-chain fatty acid and glycerophospholipid metabolism associated with hepatic steatosis. (A) mol% of SFA, MUFA, and PUFA liver content
assessed by gas chromatography. (B) Relative abundances of 6 and 3 PUFAs normalized to CON values. (C) WGCNA results. (Left) Associations between
metabolomic clusters and clinical traits; (right) associations between group and diet (right). Start_Mal_Diet and End_Mal_Diet describe malnourished versus
healthy diet, i.e., MBG/MBG-R versus CON/C-MBG and MBG/C-MBG versus CON/MBG-R, respectively. The size and color of the circle represent the Spearman
correlation coefficient between metabolomic module and clinical/group traits with significance (Padj  0.05). WGCNA randomly assigned modules a color
name. Three modules were annotated for further analyses: (i) “yellow/GP1” (positive correlation with hepatic steatosis: glycerophopholipid enriched), (ii)
“turquoise/GP2” (negative correlation with hepatic steatosis: glycerophospholipid and SFA enriched), and (iii) “red/BA” (no correlation; bile acid enriched). Data
in panels A, B, and C are from the same mouse reversal experiment (eight mice per group). Bars indicate means  SEM with statistical significance determined
by ANOVA with post hoc Tukey’s test. Further WGCNA findings are in Table S3 and Text S1 in the supplemental material.
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of 6 and 3 PUFAs within the liver. Decreased mol% of LA and LA-derived 6 PUFAs
in malnourished mice (C-MBG and MBG mice) were reversed upon dietary intervention
(MBG-R mice). While LA relative abundance was elevated in CON livers, dietary
intervention failed to shift LA percent content in MBG-R mice. Dietary intervention,
however, reversed shifts in downstream PUFA 3 members, including 20:5 3 and 22:6
3 (docosahexaenoic acid [DHA]). Despite reported PUFA alterations, 6/3 PUFA
ratios remained comparable across all groups following dietary reversal (Fig. 8B and
Fig. S6B).
While PCA and metabolite set enrichment analysis revealed diet-induced alterations
of phenylacetate, retinol, and fatty acid metabolism, the critical metabolites specifically
linked to hepatic steatosis remained uncertain. Finally, we also sought to explore
whether these metabolic shifts were associated with, or uncoupled from, microbiome
features.
To address these unknowns, we conducted undirected, weighted gene coexpression
network analysis (WGCNA) with untargeted metabolomic data. Using the WGCNA R
package (39), highly correlated metabolites were clustered into 52 modules across
samples without foreknowledge of metabolomic function. Module relationship to
clinical traits, including hepatic histology and triglyceride content, the definitive diag-
nostic features of NAFLD (4, 8), was determined by Spearman rank correlation
(Padj  0.05). Two modules significantly correlated with fatty liver traits: the “yellow”
module (positive correlation) and “turquoise” module (negative correlation). These
modules also correlated with the end diet (reversal diet), but not starting diet, indicat-
ing that metabolites within these modules were responsive to dietary intervention
(Fig. 8C). Metabolites within these modules and the “red” module, which was not
correlated with any group or clinical trait, were selected for further study and annota-
tion.
Significantly correlated modules were predominantly comprised of glycerophospho-
lipids, hereafter referred to as GP1 (for glycerophospholipid 1; yellow) (105 annotated,
183 nonannotated metabolites) and GP2 (for glycerophospholipid 2; turquoise) (243
annotated, 418 nonannotated). In contrast, the red module (28 annotated, 56 nonan-
notated metabolites) was largely comprised of cholanoic and taurocholic bile acid
metabolites and was designated BA (Table S3). While GP1 and GP2 contain PE and
phosphatidylcholine (PC) members, modules also exhibit distinct phospholipid pat-
terns. The total number and relative abundance of glycerophosphoglycerols were more
prevalent in GP1, while GP2 was enriched with glycerophosphoserines (Fig. S6C and
Table S3). In addition, GP2, but not GP1, contains SFAs. We also examined the
relationship between these modules and predicted microbiome functionality. GP1 and
GP2, but not BA, display divergent and significant correlations with key PICRUSt
pathways (Fig. S6D). This multiomic perspective not only identifies glycerophospholipid
metabolism and fatty acid metabolism as key pathways linked to hepatic steatosis but
also supports a causal role for the gut microbiota in driving undernutrition-induced
fatty liver.
DISCUSSION
While diet significantly influences NAFLD progression, NAFLD has largely been
studied as a condition associated with overnutrition rather than undernutrition (7, 8).
The MAL/MBG diet reflects dietary aberrations often observed during food insecuri-
ty—a poor diet comprised of refined carbohydrates and reduced intake of unsaturated
fats and lean proteins (23, 40, 41). This form of malnutrition exists across both
developed and developing countries (40, 42, 43). In addition, MBG mice model a
“secondary hit” contributing to persistent undernutrition—a chronic exposure to fecal
commensals due to poor sanitation/hygiene access and fecal-oral contamination (13,
44). MBG fecal contamination consists of E. coli and Bacteroidales, commensal microbes
associated with both fatty liver and undernourished cohorts (21, 22, 36).
Although this model cannot capture the complex spectrum of malnutrition and the
nonbiological forces driving health disparities in malnourished communities (e.g.,
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socioeconomic status) (12), MBG pathology provides a unique opportunity to examine
undernutrition-induced fatty liver. Here, we assessed the liver metabolome and gut
microbiome, as altered metabolic and microbial pathways drive obese-associated
NAFLD (36, 45). Further study of the undernourished gut-liver axis is needed to address
additional molecular features (e.g., liver proteomic profiling) and/or go beyond pre-
sented analyses (e.g., metatranscriptomic studies to examine hypotheses generated
from predictive PICRUSt data). Despite study limitations, MBG findings further knowl-
edge of fatty liver within the context of dietary deficiency and gut microbial dysbiosis.
Prior studies have examined how undernutrition triggers fatty liver. In a protein-
deficient rodent model, hepatic steatosis accompanied impaired mitochondrial fatty
acid oxidation and hepatic peroxisome loss. Fenofibrate treatment, a peroxisome
proliferator-activated receptor  (PPAR) stimulant, not only restored peroxisome
deficits and improved mitochondrial function but also reduced hepatic steatosis,
demonstrating a critical peroxisome-mitochondrion role in undernutrition-induced
fatty liver (9). In addition, proinflammatory mediators, epigenetic modification, and
reactive oxygen species (ROS) have also been implicated in the progression of pediatric
malnutrition (2, 10). Fatty liver features have also been associated with intrauterine
growth restriction and maternal undernutrition, further supporting a critical develop-
mental window shaping liver health trajectories (10).
Beyond diet, the gut microbiome has also been implicated in the pathology of
obese-associated fatty liver, particularly via modulation of bile acids (5, 19). Synthesized
within the liver, bile acids are secreted in the small intestine. Gut microbes modify these
primary bile acids, forming secondary bile acids (46). We have previously reported shifts
in bile acid metabolism in our malnourished model, notably reduction of both primary
and secondary tauro-conjugated bile acids, indicative of impaired host function and gut
dysbiosis. In contrast, obese NAFLD/NASH cohorts exhibit increased plasma tauro-
cholate levels (5, 47), perhaps suggestive of an overnourished NAFLD biomarker or
systemic plasma profile. Surprisingly, undirected WGCNA following dietary intervention
found no correlation between taurocholic acid module (BA) and fatty liver features, as
well as between the BA module and key microbiome pathways. These findings suggest
that alterations in taurocholic metabolism are potentially a consequence of, rather than
contributor to, hepatic steatosis within the MBG and dietary reversal models.
Here, we report two hepatic metabolomic pathways linked to the MBG micro-
biome—phenylacetate and glycerophospholipid metabolism. While diet largely shaped
the liver metabolome, hepatic steatosis was not observed following adult-onset mal-
nutrition (C-MBG mice). To identify potential metabolomic distinctions between the
MBG and C-MBG liver, we conducted metabolite set enrichment analysis which iden-
tified phenylacetic acid metabolism enriched in the MBG versus C-MBG metabolome.
Phenylacetic acid was recently identified as a driver of hepatic steatosis in a cohort of
obese, nondiabetic women (FLORINASH study). Researchers combined hepatic tran-
scriptome, plasma/urine metabolomics, and fecal metagenomics to identify signatures
and metabolic contributors of fatty liver. These multiomic analyses revealed disruption
of AAAM, a bacterial pathway producing phenylacetic acid. Chronic phenylacetic acid
exposure elevated hepatic triglyceride content, triggering NAFLD-like features in mice
(36). PICRUSt predictions from our study also revealed elevated aromatic biosynthesis
pathways in the malnourished microbiome prior to and following reversal treatment,
supporting a microbiome-dependent role in undernutrition-induced NAFLD progres-
sion.
Both metabolite set enrichment analyses and WGCNA independently report aber-
rant lipid metabolism during undernutrition, notably altered glycerophospholipid and
fatty acid metabolism. Altered glycerophospholipid profiles have been reported in
murine and human cohorts of fatty liver disease and are implicated in hepatic steatosis
pathology. For example, PE, a highly abundant mammalian glycerophospholipid, con-
tributes to lipid signaling and serves as a precursor to PC. Both elevated PE metabolism
and altered PC/PE glycerolipid ratios have been associated with fatty liver progression
(28, 48–50). In murine livers, disruption of PE biosynthesis via disruption of the
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CDP-ethanolamine pathway triggered a 10-fold increase of triacylglycerol content in
murine livers (28). While our methodology lacks the capacity to identify specific
glycerophospholipid species driving hepatic steatosis, further study to explore glycero-
phospholipids as a mechanism driving hepatic steatosis and steatohepatitis is war-
ranted.
Metabolite enrichment set analyses did highlight specific shifts in fatty acid pro-
files—PUFA metabolism. Key cell membrane components, PUFAs modulate inflamma-
tory processes, lipid signaling, and triglyceride accumulation (29, 51, 52), with 3 PUFA
supplementation recently examined as a promising NAFLD treatment (29, 53). While
MAL/MBG mice displayed a striking reduction of hepatic PUFA content, dietary inter-
vention largely restored 6 and 3 PUFA profiles.
PUFAs are metabolized via fatty acid oxidation, a catabolic process influenced by
vitamin A metabolites or retinoids. Storage and metabolism of retinoids largely occur
within liver hepatocytes and hepatic stellate cells (37). Retinoids are key regulators of
hepatic adiposity with retinaldehyde administration inhibiting diet-induced weight
gain in mice (38, 54). Beyond fatty acid regulation, retinol, retinal, and retinoic acid
contribute to diverse biological functions, including vision, adaptive T cell immunity,
and gene transcription (55, 56). Prevalent in malnourished communities, vitamin A
deficiencies drive vision impairments, growth deficits, and even mortality rates (57–59).
Largely stored in the liver, hepatic steatosis is linked to vitamin A deficiencies (60). As
both CON and MBG mice consume diets with equivalent vitamin A availability and
exhibit comparable dietary retinol levels within the liver, retinal/retinoic acid deficits in
malnourished mice likely reflect liver dysfunction (60). Like improved PUFA profiles,
dietary intervention mitigated impaired vitamin A metabolism in MBG-R mice, most
likely due to reduced hepatic steatosis. Clinical trials assessing vitamin A supplemen-
tation on anthropometric measurements in pediatric populations have reported prom-
ising, albeit inconsistent results (61, 62). These conflicting findings may result as a
consequence of undernutrition-induced fatty liver and subsequent impairment of
retinol metabolism.
In summary, we demonstrate that diet and the gut microbes alter multiple pathways
that contribute to fatty liver features in a mouse model of early-life malnutrition.
Malnutrition triggered diffuse macrovesicular lipidosis accompanied by (i) micro-
biome alterations and (ii) metabolomic shifts in phenylacetate, glycerophospho-
lipid, PUFA, and vitamin A metabolism within the MBG liver. Beyond characterizing
malnutrition-induced hepatic steatosis, our work highlights microbial-dependent
shifts in composition and function which may contribute to fatty liver pathology
and persistence. Sustained dietary intervention largely mitigated these aberrant
features, while improving growth markers and reducing fatty liver histology (Fig. 9).
In contrast, mice failed to exhibit diffuse macrovesicular lipidosis following adult-
onset malnutrition and fecal-oral contamination, despite marked shifts in micro-
biome and metabolomic profiles. These alterations may precede fatty liver pathol-
ogy in C-MBG mice maintained on a malnourished diet and/or may involve
additional disruptions not captured in our study. Alternatively, our findings raise an
intriguing possibility of a critical developmental window programming undernutrition-
induced fatty liver within this model.
Childhood malnutrition and NAFLD remain global health concerns. The prevalence
of malnutrition-induced fatty liver, specifically among pediatric populations, is ex-
pected to rise during the oncoming decades (2). Much research has examined NAFLD
linked to one arm of the malnutrition spectrum— overnutrition and obesity. Our work
provides a multifaceted assessment of undernutrition-induced fatty liver within an
early-life model that addresses global health burdens, dietary deficiency, and gut
microbiota dysbiosis (12, 13, 44). We anticipate that these findings will provide critical
launching points to identify putative dietary, microbial, and/or metabolomic targets
that address fatty liver pathology within undernourished communities.
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Mouse studies. Newly-weaned female C57BL/6J mice were purchased from Jackson Laboratory and
housed at the University of British Columbia Modified Barrier Facility (12-h light-dark cycle, ad libitum
chow and water access). Mice were randomized into experimental groups with comparable starting
weights and housed in ventilated cages filled with wood chip bedding (three to five mice per group). All
mouse studies were approved by the Animal Care Committee at the University of British Columbia and
the Canadian Council on Animal Care guidelines.
MBG model. Mice received either standard mouse chow “control diet” (catalog no. D09051102) or
an isocaloric “malnourished diet” (catalog no. D14071001) developed by Research Diets, New Brunswick,
NJ. A subset of mice on the malnourished diet were exposed to a cocktail of seven bacterial commensals
(Bacteroides vulgatus 3/1/40A, Bacteroides fragilis 3/1/12, Bacteroides ovatus 3/8/47, Bacteroides dorei
5/1/36 [D4], Parabacteroides distasonis 2/1/33B, E. coli 3/2/53, and E. coli 4/1/47) given in a 1:1 ratio.
Bacteria were plated in anaerobic conditions on fastidious anaerobe agar prior to oral gavage (100 l).
Following 2 weeks (week 5) on the control or malnourished diet, all mice received a series of three
gavages administered every other day: MBG (109 bacterial cells/ml in sterile, reduced phosphate-buffered
saline [PBS]), non-MBG groups (sterile, reduced PBS). Full methodology and further dietary reports are
provided in references 13 and 20. Upon sexual maturation, 6 weeks, mice were considered adults.
Micro-CT. Micro-CT scans were completed on 7-week-old anesthetized (isoflurane) mice within the
Centre for High-Throughput Phenogenomics at the University of British Columbia using the eXplore CT
120 (TriFoil Imaging, Chatsworth, CA, USA). Micro-CT scanning was conducted with in-house protocols
(rotation mode, continuous; single scan time, 4 min; entrance dose, 175 mGy). Image data sets were
reconstructed into three-dimensional volumes (isotropic voxel size, 100 m). On the basis of published
methodology (63), we classified tissues into adipose, lean, and bone tissue with MicroView software (GE
Healthcare Biosciences) with the following signal-intensity thresholds 200 to 275, 30 to 40, and
190 to 250 HU, respectively.
Histology measurements. Individual liver lobes were stored in 10% formalin for 12 to 24 h at room
temperature. Following formalin storage, tissues were transferred into 70% ethanol. Paraffin-embedded
tissues were sliced and stained with H&E using established practices by the Biomedical Research Centre
(Ingrid Barta) or Wax-it Histology Services at the University of British Columbia. H&E tissues were imaged
under a light microscope at 40, and the percentage of fat- or fat/glycogen-associated per image was
determined by Fiji (Image J) on 8-bit images. The threshold of “open” space was set by CON histology,
and the same threshold settings were applied to all samples.
Ex vivo cytokine quantification. Liver tissues were collected for cytokine analysis. Tissue samples
were stored in 1 ml of PBS with cOmplete EDTA-free protease inhibitor prior to homogenization and
FIG 9 Multihit model of undernutrition-induced fatty liver and dietary intervention. Chronic exposure to specific, fecal
microbes impacts hepatic steatosis and triglyceride accumulation in malnourished mice. Early-life malnutrition triggers an
altered liver metabolome characterized by shifts in phenylacetate (phenylacetic acid [PA]), vitamin A (retinoids [A, a]),
long-chain fatty acid, and glycerophospholipid metabolism. These changes are accompanied by striking alterations in gut
microbiota community and function. Notably, enriched metabolism of phenylacetic acid, a bacterial product of AAAM
metabolism, corresponds with increased relative frequency of AAAM predicted microbiome pathways in MBG mice, while
altered glycerophospholipid metabolism correlates with both microbiome functional profiles and hepatic steatosis. Adult-
onset malnutrition elicits metabolomic shifts largely uncoupled from hepatic steatosis (not shown), highlighting the impor-
tance of an early-life development period in liver function. In contrast, sustained dietary intervention largely mitigates
microbial and host metabolic shifts during malnutrition, reducing hepatic steatosis and improving growth. Collectively, these
findings demonstrate a putative role for commensal gut microbes in NAFLD and highlight putative host/microbial targets to
reduce fatty liver burden in undernourished communities. This figure was created using Biorender.
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frozen at 70/80°C. Tissue homogenates were centrifuged at top speed (16,000  g) for 15 min at
4°C, and the resulting supernatants were stored at 80°C. Cytokine levels from liver supernatants were
measured using the BD Biosciences cytometric bead array mouse inflammation kit. All cytokine concen-
trations were normalized to starting tissue weight.
Triglyceride, glucose, and insulin. Triglyceride measurements were determined from liver super-
natants using the abcam triglyceride assay kit (ab65336). Triglyceride levels were first normalized to
starting tissue weight and then compared against CON samples. Following euthanasia, blood was
collected from nonfasted and fasted (overnight) mice. Immediately upon collection, blood glucose was
measured via glucometer, while insulin levels were measured from mouse sera by ALPCO Mouse Insulin
ELISA kit (catalog no. 80-INSMS-E10). Enzyme-linked immunosorbent assays (ELISAs) were completed
according to the manufacturer’s recommendations.
Untargeted metabolomics and metaboanalyst analyses. Untargeted metabolomics (RP-UPLC-
FTMS, HILIC-FTMS) were conducted by The Metabolomics Innovation Centre. Murine liver lobes were
collected and weighed postmortem. Prior to analyses, tissues were kept in storage at 70/80°C.
(i) RP-UPLC-FTMS analysis. Individual mouse liver tissues in 5 l water/mg of liver tissue, plus two
4-mm metal balls were homogenized on a MM 400 mill (2, 30 Hz for 1 min). Following a 5-s spin down,
methanol-chloroform (4:1) at 25 l/mg liver tissue was added to the Eppendorf tube. Following repeated
homogenization method, samples were placed in an ice-water bath for sonication (5 min) and centri-
fuged for 20 min (15,000 rpm, 10°C). A 60-l aliquot of supernatant from each sample was dried using
the same nitrogen evaporator, and subsequent residue was reconstituted in 80% methanol (40 l).
Ten-microliter portions of these samples were used for reversed-phase RP-UPLC-FTMS. RP-UPLC-FTMS
runs utilized the Waters BEH C8 (2.1  50 mm, 1.7 m) column with 0.01% formic acid in water (mobile
phase A) and 0.01% formic acid in 1:1 acetonitrile-isopropanol (mobile phase B). The mobile phase
elution gradient was 5 min for 5% to 50% in mobile phase B, 15 min for 50% to 100% in mobile phase
B, and 2 min in 100% mobile phase B. The column temperature was maintained at 60°C with a flow rate
of 400 l/min. Full RPLC-FTMS methodology is reported at the NIH Common Fund’s Data Repository and
Coordinating Center website (studies ST001367 and ST001368).
(ii) HILIC-FTMS analysis. Individual sample supernatants were mixed with 120 l of water, 180 l of
methanol, and 195 l of chloroform. The mixture was vortex mixed at 3,000 rpm for 30 s before
centrifugal clarification. Three hundred microliters of the upper, aqueous phase was precisely taken out
and transferred to a “V”-shape LC injection microvial and dried down under a gentle nitrogen gas flow
in the nitrogen evaporator. The residue was reconstituted in 50 l of 80% acetonitrile. Ten microliters was
injected for HILIC-FTMS.
HILIC-FTMS was performed on a Waters HILIC column (2.1  100 mm, 1.8 m) for chromatographic
separation of very polar metabolites. The mobile phase was as follows: mobile phase A was 0.01% formic
acid in water, and mobile phase B was 0.01% formic acid in acetonitrile. For binary gradient elution, 85%
mobile phase B for 1 min; 85% to 25% mobile phase B in 8 min, followed by column equilibration at 85%
mobile phase B for 6 min between injections. The flow rate was 0.3 ml/min, and the column temperature
was 30°C. The MS instrument was run in the survey scan mode with FTMS detection at a mass resolution
of 60,000 full width at half maximum (FWHM) at m/z 400. Two HILIC-FTMS data sets were acquired for
each sample, one with positive-ion detection and the other with negative-ion detection. The mass scan
range was m/z 80 to 800.
(iii) Data processing and analyses. Data processing and analyses were conducted with XCMS
(https://xcmsonline.scripps.edu/) in R to procure m/z (mass-to-charge ratio), retention time (RT) (in
minutes), and LC-MS peak areas. To assign the metabolite candidates of any potential biomarkers, the
measured m/z’s were searched against metabolome databases, namely, METLIN (Scripps Research
Institute) with mass errors of 3 ppm. For positive ion detection data, (M	H)	, (M	Na)	, (M-
H2O	H)	, and (M-NH3	H)	 were allowed in database searches. For negative ion detection, (M-H)-,
(M	Na-2H)-, (M-H2O-H)-, and (M-NH3-H)- were allowed. PCA plots, enrichment analyses, and pathway
analyses were carried out using Metaboanalyst v. 4.0 software: mass tolerance, 0.0003; retention time
tolerance, 30; data filtering, nonparametric relative standard deviation (MAD/median), normalized from
pooled CON samples, log transformation, and auto data scaling. A one-way ANOVA was used to
determine significant changes between groups (Padj  0.05; fold change 2). Analyses were completed
based on previously reported studies (13). All metabolite set enrichment analyses were conducted using
small molecule pathway database (SMPDB), unless otherwise stated.
Vitamin A metabolomics. Vitamin A metabolites were assessed at The Metabolomics Innovation
Centre. Mouse liver tissue was homogenized in 50% aqueous methanol (25 l/mg tissue) in Eppendorf
tubes with two 4-mm metal balls/tube using the MM 400 mixer mill (shaking frequency, 30 Hz for
1 min  2), followed by sonication in a water bath for 2 min. Hexane (50 l/mg tissue) containing
20 g/ml butylated hydroxytoluene (BHT) (antioxidant) was added to the tube. The mixture was vortex
mixed at 3,000 rpm for 30 s before 6-min centrifugation at 15,000 rpm, and at 10°C, the whole phase was
split into an upper organic phase and a lower aqueous phase. The organic phase was removed with a
gel-loading tip, and the aqueous phase was extracted with hexane again at 50 l/mg tissue. After
centrifugation, the organic-phase extracts from two rounds of liquid-liquid extraction were combined
and then dried in a nitrogen evaporator. The residue was dissolved in methanol (5 l per mg tissue),
containing 0.5 g/ml of beta-tocopherol-D3 as internal standard. 10 l of sample was injected to a C8
UPLC column (2.1  50 mm, 1.7 m) to run UPLC-high-resolution MS on a Thermo Scientific LTQ-Orbitrap
mass spectrometer, which was operated with positive-ion FTMS detection at 60,000 FWHM (m/z 400) in
a mass scan range of m/z 100 to 1800. Serially diluted, mixed standard solutions of fat-soluble vitamin
A (retinol, retinal, and retinoid acid) in a concentration range of 0.01 to 100 nmol/ml per compound were
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prepared in the same internal standard solution, and 10-l aliquots were injected to acquire the data to
construct the linear calibration curves for the quantitation. The mobile phases were a 5 M silver-ion
solution (mobile phase A) and acetonitrile-isopropanol (1:1) (mobile phase B) for binary-solvent gradient
elution, with a gradient of 30% to 100% mobile phase B in 10 min at a flow rate of 250 l/min. Vitamin
A concentrations were calculated from the linear regression calibration curves of their standard com-
pounds.
Liver fatty acid profile. Liver tissues were collected and immediately placed in dry ice prior to
storage at 70/80°C prior to processing. Liver tissues (50 mg  sample) were homogenized at 4°C with
an Ultra-Turrax homogenizer (IKA, Staufen, Germany) in homogenization buffer (1 M 2,6-di-tert-butyl-
4-methylphenol, 1 mM diethylenetriamine penta-acetic acid, 2 mM ethylenediamine tetra-acetic acid, 5
mM 3-(N-morpholino)propanesulfonic acid, with 180 mM potassium chloride, and adjusted to pH 7.4).
Samples were normalized by protein content (Bradford assay). Tissue fatty acid profiles were based on
reported methodology (64).
(i) Fatty acid methyl ester preparation. Total lipids from liver homogenates were extracted via
chloroform-methanol (2:1 [vol/vol]; 3 times) with 0.01% butylated hydroxytoluene. The chloroform phase
was evaporated under nitrogen, and the fatty acids were transesterified by incubation in 2.5 ml of 5%
methanolic HCl at 75°C for 90 min. Following transesterification, 2.5 ml of n-pentane and 1 ml of
saturated NaCl solution were added to extract fatty acid methyl esters (FAMEs). The n-pentane phase was
separated, evaporated under N2 gas, and redissolved in 80 l of carbon disulfide. Two microliters was
used for subsequent GC analysis.
(ii) Gas chromatography conditions. Gas chromatography analyses was performed on a GC system
7890A with a series injector 7683B and a flame ionization detector (Agilent Technologies, Barcelona,
Spain), equipped with a DBWAX capillary column (length of 30 m, inner diameter of 0.25 mm, and film
thickness of 0.20 m). The injection port was maintained at 220°C and the detector at 250°C. Injections
were performed using the splitless mode. The flow rate of carrier gas (helium 99.99%) was maintained
at 1.8 ml/min. The temperature program was 5 min at 145°C, then 2°C/min to 245°C, and finally, the
temperature was held at 245°C for 10 min with a postrun of 250°C for 10 min.
(iii) Data analysis. Identification of FAMEs was made by comparison with authentic standards
(Larodan Fine Chemicals, Malmö, Sweden). The fatty acid profile detected plus identified plus quantified
represents more than 95% of the total chromatogram. Results were expressed as percent moles. Here,
we normalized against pooled CON samples.
Microbiome and multiomic analyses. (i) 16S sequencing and analyses. Collected fecal pellets
were stored in 70°C prior to DNA isolation with the QIAamp PowerFecal DNA kit (Qiagen catalog no.
12830). Library preparation for 16S rRNA sequencing was performed with barcoded primers (V4 region)
as described in reference 65. Upon ensuring successful amplification via gel electrophoresis, PCR
amplicons were cleaned and normalized with the Sequal-Prep kit (ThermoFisher catalog no. A1051001),
pooled, and sequenced on an Illumina MiSeq (v2 kit, 2  250 bp reads).
Demultiplexed reads were analyzed and annotated in QIIME2 (v 2018.2) using the DADA2 pipeline
(sampling depth of 22051 bp) and Greengenes 97% operational taxonomic units (OTUs) (66–68). Addi-
tional filtering excluded contaminants (mitochondria, chloroplast). QIIME provided Padj for bacterial
families. Downstream microbiome analyses and visualization were performed in R; further details are
provided in Text S1 in the supplemental material.
(ii) PICRUSt. To assess functional changes in the fecal microbiota, we conducted PICRUSt (v2.1.3b).
The full output is available in Table S2. Metabolic pathways were annotated using MetaCyc (35, 69).
(iii) WGCNA. WGCNA R package (39) identified metabolomic modules (modular eigengene) that
correlated with both clinical features, traits, and PICRUSt output (Spearman rank correlation test,
Padj  0.05). WGCNA was completed on the less polar metabolomic data (positive run) following
normalization (as described above in “Untargeted metabolomics and metaboanalyst analyses”). On the
basis of a scale-free topology, we chose a soft threshold   13. Modules containing 5 metabolites
were identified, and full clustering criteria and the R code are given in Text S1. Modules were
auto-labeled by color. Metabolites within modules of interest were auto-annotated using MassTRIX: Mass
TRanslator into Pathways v. 3 (70) (Table S3).
Statistical analysis. Statistical analyses provided were performed with GraphPad Prism software
version 7.00/8.00. Results are expressed as the means with standard error of the means (SEM), unless
otherwise stated.
Data availability. The data sets generated and/or analyzed during the current study are available
from the corresponding author upon request. Microbiome and WGCNA pipelines are reported in Text S1.
Raw metabolomic data have been deposited at the NIH Common Fund’s National Metabolomics Data
Repository (NMDR) website, the Metabolomics Workbench (https://www.metabolomicsworkbench.org),
where it has been assigned study identifier (ID) PR000935. These data can be accessed directly via
https://doi.org/10.21228/M8TT3R. NMDR is supported by NIH grant U2C-DK119886. Raw 16S sequencing
has been deposited in the NCBI Sequence Read Archive (SRA) under accession number PRJNA629327.
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